Agonist
| Category | Glossary |
|---|---|
| Also known as | Full Agonist, Receptor Activator |
| Last updated | 2026-04-14 |
| Reading time | 3 min read |
| Tags | pharmacologyreceptorssignalingglossary |
Overview
An agonist is a ligand that binds to a receptor and triggers the conformational change required to initiate a downstream signaling cascade. Agonists mimic or substitute for the body's endogenous messengers — hormones, neurotransmitters, cytokines, or growth factors — and are a cornerstone concept in pharmacology and peptide therapeutics.
In the language of receptor theory, a full agonist produces the maximal response achievable by that receptor system, regardless of concentration. Most therapeutic peptides marketed today, including GLP-1 analogs and growth hormone secretagogues, are designed to act as agonists at specific receptors.
Detailed Explanation
Agonism depends on two distinct properties: binding affinity and intrinsic efficacy. Affinity describes how tightly the molecule occupies its receptor — a high-affinity agonist binds even at low concentrations. Efficacy describes what happens after binding: how effectively the bound agonist stabilizes the active conformation of the receptor and couples it to downstream signaling.
A molecule with high affinity but zero efficacy is an antagonist. A molecule with high affinity and partial efficacy is a partial agonist. A molecule with high affinity and negative efficacy (suppressing basal activity) is an inverse agonist.
When an agonist binds a G-protein-coupled receptor (GPCR), it stabilizes conformations that recruit G-proteins or β-arrestin, activating second messenger cascades such as cyclic AMP, IP3/DAG, or MAP kinase pathways. For tyrosine kinase receptors, agonist binding promotes dimerization and autophosphorylation, triggering signaling relays that alter gene expression through transcription factors.
Key Concepts
- EC50: The concentration of an agonist that produces 50% of its maximal effect. See EC50.
- Intrinsic activity: The ratio of an agonist's maximal response to that of a reference full agonist (1.0 = full, <1.0 = partial).
- Spare receptors: When an agonist produces a maximal response while occupying only a fraction of available receptors.
- Desensitization: Prolonged agonist exposure often triggers receptor desensitization and internalization via receptor trafficking.
Relevance to Peptides
Peptide agonists are attractive drug candidates because they can be designed with high receptor selectivity, mimicking the natural ligand's binding mode. Examples include:
- GLP-1 receptor agonists (semaglutide, tirzepatide) for metabolic disease
- Growth hormone secretagogue receptor agonists (ipamorelin, CJC-1295)
- Melanocortin receptor agonists (melanotan II, PT-141)
Peptide agonists must be protected against protease degradation to reach their target receptor — often through PEGylation, cyclization, or unnatural amino acid substitutions.
Measurement
Agonist potency and efficacy are characterized using dose-response assays that produce a dose-response curve. From the curve, researchers extract the EC50 and maximal efficacy (Emax). Binding affinity is measured separately, typically using radiolabel displacement or surface plasmon resonance.
Summary
An agonist binds and activates its receptor to produce a biological response. Understanding the affinity-efficacy distinction, the role of second messengers, and mechanisms like negative feedback is essential for interpreting peptide pharmacology and therapeutic design.
Related entries
- Antagonist— A molecule that binds a receptor without activating it, blocking the action of endogenous agonists and reducing or abolishing downstream signaling.
- Biased Agonism— A pharmacological phenomenon in which different ligands of the same receptor preferentially activate distinct downstream signaling pathways, rather than all pathways equally.
- Inverse Agonist— A ligand that binds a receptor and stabilizes its inactive conformation, reducing constitutive (basal) signaling below the untreated baseline.
- Ligand— A molecule — peptide, small molecule, ion, or biomacromolecule — that binds specifically to a defined site on a receptor or other target protein.
- Partial Agonist— A ligand that binds a receptor and activates it submaximally, producing a smaller maximal response than a full agonist even at saturating concentrations.
- Receptor Agonist— A molecule that binds to a biological receptor and activates it, triggering the same intracellular signaling response as the receptor's natural ligand — a foundational concept in peptide pharmacology.
- Biased Agonism— A pharmacological concept in which different ligands at the same receptor preferentially activate distinct downstream pathways.